1. Home
  2. BEAT vs CFND Comparison

BEAT vs CFND Comparison

Compare BEAT & CFND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • CFND
  • Stock Information
  • Founded
  • BEAT 2015
  • CFND N/A
  • Country
  • BEAT United States
  • CFND
  • Employees
  • BEAT N/A
  • CFND N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • CFND
  • Sector
  • BEAT Technology
  • CFND
  • Exchange
  • BEAT Nasdaq
  • CFND Nasdaq
  • Market Cap
  • BEAT 63.5M
  • CFND 51.2M
  • IPO Year
  • BEAT 2021
  • CFND 2025
  • Fundamental
  • Price
  • BEAT $1.56
  • CFND $6.63
  • Analyst Decision
  • BEAT Buy
  • CFND
  • Analyst Count
  • BEAT 1
  • CFND 0
  • Target Price
  • BEAT $8.00
  • CFND N/A
  • AVG Volume (30 Days)
  • BEAT 86.1K
  • CFND N/A
  • Earning Date
  • BEAT 11-13-2025
  • CFND N/A
  • Dividend Yield
  • BEAT N/A
  • CFND N/A
  • EPS Growth
  • BEAT N/A
  • CFND N/A
  • EPS
  • BEAT N/A
  • CFND N/A
  • Revenue
  • BEAT N/A
  • CFND N/A
  • Revenue This Year
  • BEAT N/A
  • CFND N/A
  • Revenue Next Year
  • BEAT $28.23
  • CFND N/A
  • P/E Ratio
  • BEAT N/A
  • CFND N/A
  • Revenue Growth
  • BEAT N/A
  • CFND N/A
  • 52 Week Low
  • BEAT $0.91
  • CFND N/A
  • 52 Week High
  • BEAT $3.48
  • CFND N/A
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 44.23
  • CFND N/A
  • Support Level
  • BEAT $1.62
  • CFND N/A
  • Resistance Level
  • BEAT $1.74
  • CFND N/A
  • Average True Range (ATR)
  • BEAT 0.13
  • CFND 0.00
  • MACD
  • BEAT -0.01
  • CFND 0.00
  • Stochastic Oscillator
  • BEAT 30.88
  • CFND 0.00

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About CFND C1 Fund Inc.

C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.

Share on Social Networks: